Clinical Trials Browser

Interventional × Disease × Transplantation, Autologous × Clear all

NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma, Neoplasms, Plasma Cell